Brief: Oramed Receives $18 Million Payment From Scilex Holdings
07/01/2026 14:20
Jan 7 (Reuters) - Oramed Pharmaceuticals Inc ORMP.O: ORAMED RECEIVES $18 MILLION PAYMENT FROM SCILEX HOLDINGS, BRINGING CURRENT RETURNS TO $118 MILLION; BOARD APPROVES DIVIDEND PAYMENTS ORAMED PHARMACEUTICALS INC - RETAINS $27 MILLION NOTE AND $12 MILLION CONVERTIBLE NOTE ORAMED PHARMACEUTICALS INC: ALSO MAINTAINS ITS WARRANT POSITION AS WELL AS A NINE-YEAR ROYALTY INTEREST IN SCILEX PRODUCTS Source text: ID:nPn4LdQwYa Further company coverage: ORMP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oramed Pharmaceuticals
See all newsBrief: Nano Dimension Appoints Nadav Kidron To Board Of Directors To Chair Strategy And Capital Allocation Committee
Oramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview
Brief: Oramed And Lifeward Announce Strategic Transaction
Brief: Oramed Receives $18 Million Payment From Scilex Holdings
Brief: Oramed Reports Fiscal Third Quarter 2025 Financial Results